mRNA expression
Gene:
BAGE (official gene symbol)Other symbol:
BAGECT family:
CT2CT identifier:
CT2.1Aliases from NCBI:
BAGE1Unified entry for BAGE, BAGE2, BAGE3, BAGE4, BAGE5
Gene expression pattern ? : Testis-selective
High-throughput data (expression in cancer samples)
SAGE(short, 10 nt tags) Show
SAGE(long, 17 nt tags) Show
MPSS (short, 13 nt tags) Show
EST Show
Validation by Ludwig Institute of Cancer Research of mRNA expression in normal tissues and cell lines (RT-PCR)
Show![]() | ||
![]() | ||
The figures shown in this section represent a standardized analysis of all reported CT-antigens in the same set of mRNA preparations from
normal human tissues and a selection of human cancer cell lines. The analysis was done by RT-PCR using the primer pairs indicated for each gene.
A total of 1.0 �g of RNA was reverse-transcribed into cDNA using the Omniscript RT kit (Qiagen, Valencia, CA) using oligo (dT)18 primers
(Invitrogen, Carlsbad, CA). JumpStart REDTaq� ReadyMix-(Sigma Aldrich, St. Louis,MO) was used for amplification according to the manufacturer's
instructions. Samples were amplified with a precycling hold at 95oC for 3 min, followed by 35 specific cycles of denaturation at 95oC
for 15 seconds,annealing for 30 seconds (10 cycles at 60oC, 10 cycles at 58oC and 15 cycles at 56oC) and extension at 72oC for 30 seconds followed by a final
extension step at 72oC for 7 minutes. The RT-PCR products were run on 1.5% agarose gels and stained by ethidium bromide. |
Published data of mRNA expression in normal tissues
ShowTissue | Methodology | PMID |
---|---|---|
Testis | RT-PCR | 12461691 |
Testis | RT-PCR | 7895173 |
Testis | RT-PCR | 14738373 |
Testis | RT-PCR | 18237105 |
Placenta | RT-PCR | 18237105 |
Spleen | RT-PCR | 18237105 |
Lung | RT-PCR | 18237105 |
Published data of mRNA expression in neoplasias
Hematologic malignacies Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Myeloma |
15/55 (27%) | RT-PCR | 17023585 | |
Monoclonal gammopathy of undetermined significance (MGUS) |
0/6 (0%) | RT-PCR | 10438702 | |
Myeloma |
0/2 (0%)(stage II) | RT-PCR | ||
Myeloma |
0/9 (0%)(stage I) | RT-PCR | ||
Myeloma |
7/26 (27%)(stage III) | RT-PCR | ||
Myeloma |
12/39 (33%) | RT-PCR | 18237105 |
Head & Neck cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Squamous cell carcinoma |
Primary tumor | 1/57 (2%) | RT-PCR | 20715104 |
Hepatobiliary cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Hepatocellular carcinoma |
1/10 (10%)(Well differentiated) | RT-PCR | 10782910 | |
Hepatocellular carcinoma |
0/2 (0%)(Poorly differentiated) | RT-PCR | ||
Hepatocellular carcinoma |
6/20 (30%)(Mod differentiated) | RT-PCR |
Lung cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Non small cell lung carcinoma |
8/46 (17%) | RT-PCR | 15201976 | |
Non small cell lung carcinoma |
9/42(20%) | RT-PCR | 14512184 | |
Small cell lung carcinoma |
2/4 (50%) | RT-PCR | ||
Non small cell lung carcinoma |
4/64 (6%) | RT-PCR | 7895173 |
Melanocytic lesion Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Melanoma |
Primary tumor | 2/26 (8%) | RT-PCR | 12461691 |
Melanoma |
Metastatic tumor | 12/77 (15%) | RT-PCR | |
Melanoma |
Primary tumor | 3/38 (8%) | RT-PCR | 7895173 |
Melanoma |
Metastatic tumor | 37/140 (26%) | RT-PCR |
Ovarian cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Mucinous ovarian carcinoma |
Peritoneal fluid | 2/5 (40%) | RT-PCR | 12115308 |
Papillary ovarian carcinoma |
Peritoneal fluid | 6/11 (54%) | RT-PCR | |
Serous-papillary ovarian carcinoma |
Peritoneal fluid | 6/11 (54%) | RT-PCR |
Published data of mRNA expression in Cell Lines
ShowOrigin tissue | Cell Line ID | Frequency | Methodology | PMID |
---|---|---|---|---|
Glioblastoma multiforme | U87MG SNB19 ONS-23 |
3/4 (75%) | RT-PCR | 20082319 |
Hepatocellular carcinoma | SMMC-7721 QQY-7701 |
2/3 (67%) | RT-PCR | 14607688 |
Myeloma | SBN XG2 XG6 XG7 AMO-1 Karpas 620 L363 NCI-H929 0PM2 RPMI-8226 |
10/17 (59%) | RT-PCR | 10741395 |
Myeloma | MOLP-8 KMS-12-BM EJM IM9 RPMI-8226 NCI-H929 U-266 Brown SK-007 |
9/11 (82%) | RT-PCR | 17023585 |
2005-2009© CT Antigens Database